Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Citi raises Micron Technology price target to $1,300
• Union Pacific (UNP) Reiterated at Market Outperform by Citizens - Most Attractive in Rail Group